PGNY: financial statements from SEC — TradeAlmanac

PGNY

Progyny, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Revenue	329m	318m	313m	333m	324m	298m	287m	304m
Cost of revenue	245m	242m	241m	254m	248m	235m	227m	236m
Gross profit	83m	77m	73m	79m	76m	63m	59m	68m
Selling, general and administrative	31m	44m	33m	36m	34m	32m	30m	31m
Operating expenses	48m	62m	51m	55m	52m	48m	47m	48m
Operating income	35m	15m	22m	24m	24m	16m	12m	21m
Pre-tax income	37m	18m	24m	27m	27m	18m	18m	25m
Income tax	13m	5m	10m	10m	11m	7m	8m	9m
Net income	24m	12m	14m	17m	15m	11m	10m	16m
Earnings per share	0.30	0.15	0.16	0.20	0.18	0.12	0.12	0.18
Earnings per share, diluted	0.29	0.14	0.15	0.19	0.17	0.12	0.11	0.17
Weighted average shares	81m	85m	86m	86m	85m	86m	90m	94m
Weighted average shares, diluted	85m	89m	90m	90m	89m	89m	94m	98m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	132m	112m	134m	133m	109m	162m	91m	95m
Receivables	264m	220m	253m

Cash flow

Metric	Mar 31, 2026	Mar 31, 2025
Operating cash flow	46m	50m
Depreciation and amortisation	1m	1m
Share-based compensation	20m	33m
Capital expenditure	6m	3m
Investing cash flow	97m	−95m
Share buybacks	119m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)